28. November 2009 01:16
Research and Markets (http://www.researchandmarkets.com/research/1b2b29/intranasal_drug_de) has announced the addition of the "Intranasal Drug Delivery - US Market Trends & Analysis" report to their offering.
The US intranasal drug delivery market is witnessing an expansion of therapeutic applications from the delivery of conventional local therapeutic drugs to the delivery of systemic therapeutic drugs. The future of the technology hinges onto the effective exploitation of the fact that the nose offers an en-route that bypasses the blood-brain barrier through the olfactory region. The market also stands enthused by the continuous research and development activities, which are gradually opening up opportunities in new therapeutic areas, such as, osteoporosis, pain management, vitamin B12 deficiency, smoking cessation, migraines, nocturnal enuresis, rheumatoid arthritis, sexual dysfunction, cancer therapy, insulin-dependent diabetes, and epilepsy.
These and other market data and trends are presented in "Intranasal Drug Delivery: US Market Trends & Analysis" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
http://www.researchandmarkets.com/research/1b2b29/intranasal_drug_de
32707a94-871d-4a04-b5a5-bb3b43ec10b0|0|.0
Posted in: Pharmaceutical News
Tags: Arthritis, Brain, Cancer, Diabetes, Drug Delivery, Epilepsy, Insulin, Osteoporosis, Pfizer, Rheumatoid Arthritis, Smoking
News-Medical.Net provides this medical information service in accordance
with these
terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.
Subscribe